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Abstract
The fungal pathogen Candida glabrata has risen from an innocuous commensal to a major human pathogen that causes
life-threatening infections with an associated mortality rate of up to 50%. The dramatic rise in the number of
immunocompromised individuals from HIV infection, tuberculosis, and as a result of immunosuppressive regimens in cancer
treatment and transplant interventions have created a new and hitherto unchartered niche for the proliferation of C.
glabrata. Iron acquisition is a known microbial virulence determinant and human diseases of iron overload have been found
to correlate with increased bacterial burden. Given that more than 2 billion people worldwide suffer from iron deficiency
and that iron overload is one of the most common single-gene inherited diseases, it is important to understand whether
host iron status may influence C. glabrata infectious disease progression. Here we identify Sit1 as the sole siderophore-iron
transporter in C. glabrata and demonstrate that siderophore-mediated iron acquisition is critical for enhancing C. glabrata
survival to the microbicidal activities of macrophages. Within the Sit1 transporter, we identify a conserved extracellular
SIderophore Transporter Domain (SITD) that is critical for siderophore-mediated ability of C. glabrata to resist macrophage
killing. Using macrophage models of human iron overload disease, we demonstrate that C. glabrata senses altered iron
levels within the phagosomal compartment. Moreover, Sit1 functions as a determinant for C. glabrata to survive
macrophage killing in a manner that is dependent on macrophage iron status. These studies suggest that host iron status is
a modifier of infectious disease that modulates the dependence on distinct mechanisms of microbial Fe acquisition.
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Introduction
Candida glabrata has emerged as an opportunistic fungal
pathogen that causes life-threatening infectious disease in humans
[1]. The dramatic rise in the number of immunocompromised
individuals due to HIV infection and tuberculosis, and as a result
of immunosuppressive regimens in cancer treatment and trans-
plant interventions, have provided fertile ground for unchecked C.
glabrata proliferation. While Candida species now account for over
10% of all bloodstream infections [2], the poor susceptibility of C.
glabrata to antifungal therapeutics is in great part responsible for
the high mortality rate of up to 50% associated with C. glabrata
candidemia [3,4]. The limited knowledge of virulence factors that
contribute to the pathogenesis of C. glabrata demands insights into
the biology of this opportunistic pathogen that contribute towards
the successful colonization of the mammalian host.
Iron (Fe) is an essential metal for virtually all organisms. The
ability of Fe to cycle between the reduced ferrous (Fe
2+) and
oxidized ferric (Fe
3+) forms endows it with redox versatility that is
utilized in both catalysis and structural biology. However, Fe
2+
also has the potential to generate damaging reactive oxygen
species (ROS) via Fenton/Haber Weiss chemistry [5] and, as a
consequence, organisms have evolved sophisticated homeostatic
mechanisms to tightly regulate the acquisition, utilization, storage
and mobilization of Fe [6,7].
Eukaryotic Fe homeostasis has best been described in the
budding yeast, Saccharomyces cerevisiae that possesses two high-
affinity mechanisms of Fe acquisition [7]. In an aerobic
environment, Fe is oxidized and largely insoluble [8] and one
mechanism relies on the reduction of environmental Fe sources by
cell surface reductases and transport through a ferroxidase/
permease complex composed of the Fet3 and Ftr1 proteins,
respectively. The activity of the Fet3 Cu-dependent ferroxidase is
essential for Fe transport through Ftr1 and, thus, reductive high-
affinity Fe assimilation is dependent on adequate cellular Cu
bioavailability. Alternatively, S. cerevisiae expresses cell surface
siderophore transporters. Synthesized and secreted by most
bacteria and fungi as well as some higher plants, siderophores
are low molecular weight organic chelators with high affinity for
Fe
3+ (binding constants between 10
23 M and 10
49 M). Given the
low Fe bioavailability in an aqueous environment (free Fe
3+
concentration below 10
29 M at pH 7) and the further strict active
withholding of Fe within mammalian hosts (free serum Fe
concentration of approximately 10
224 M) [9], siderophores
represent a powerful and widespread mechanism for microbial
Fe scavenging. This is underscored by the fact that bacteria and
fungi have evolved transporters that allow them to utilize
siderophores they themselves do not produce (xenosiderophores)
and several fungi, such as Candida species, and bacteria do not
possess the ability to synthesize siderophores yet express
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of Fe homeostasis in Candida albicans, similar to most fungi, differ
significantly from that of S. cerevisiae and C. glabrata [10], iron-
regulated CaSit1 shares high homology with S. cerevisiae side-
rophore transporters and its deletion compromises utilization of
fungal ferrichrome-type hydroxamate siderophores. CaSit1 has
been shown to be required for the invasion and penetration of
human epithelial cells in an in vitro model of oral candidiasis but
was not required for murine systemic candida dissemination [11],
possibly reflecting the sterile environment of the serum in which
siderophore concentrations are predicted to be negligible. The
absence of an identifiable heme receptor in C. glabrata present in
Candida albicans [12], suggests that C. glabrata may rely predomi-
nantly on the solubilization of the circulating exchangeable Fe
pool to meet its requirements for Fe. Given that mammals are host
to a formidable number of microbial species, the aggressive
exploitation of local siderophore reservoirs that allows for high-
affinity Fe uptake from virtually any host ligand is likely to play a
critical role in microbial virulence.
Mammalian cellular immunity relies heavily on the action of
macrophages, cells that also play a critical role in systemic Fe
homeostasis [13]. A key mechanism through which macrophages
mediate microbial containment is through the localized reduction
of serum transferrin-bound Fe, decreased Fe export and the
depletion of Fe from the macrophage phagosome, an intracellular
compartment that surrounds ingested microorganims. These
macrophage activities promote the killing of microorganisms by
depriving them of Fe essential not only for cellular biochemistry
but also for incorporation into microbial ROS-detoxifying
enzymes, such as catalase or superoxide dismutase, that are
critical to resistance to high levels of oxidative stress generated in
the phagosome [14]. Emerging evidence for increased infections in
patients with Fe overload disease highlights the strict requirement
for tight host Fe restriction in microbial containment [15].
Hereditary hemochromatosis (HH) is the most common single-
gene disorder affecting Caucasian individuals of European descent
[16]. Mutations associated with HH are found in the gene
encoding the Fe exporter, ferroportin (Fpn), in HAMP, encoding
the peptide hormone hepcidin and negative regulator of Fpn, as
well as in genes encoding regulators of HAMP expression.
Hepcidin expression and release from the liver leads to targeted
Fpn degradation at a systemic level resulting in a block in dietary
Fe uptake through enterocytes and a block in Fe release from
macrophage and hepatocyte stores [17]. Although several of the
mutations that underlie HH lead to similar outcomes of
pathophysiological Fe overload in parenchymal organs, the clinical
presentations differ with regard to macrophage Fe levels which are
low when hepcidin levels are low or fails to be recognized by Fpn,
and high when hepcidin levels increase or Fpn Fe-export activity is
compromised. Given the critical role of macrophages in immunity,
the dominant effects of Fpn activity on macrophage Fe status may
be predicted to impinge on their immuno-protective functions.
Here we describe the C. glabrata Sit1 siderophore transporter, its
regulation under Fe deficiency and substrate siderophore specific-
ity. In infection assays using both mouse and human macrophage
cell lines we observe a strong Sit1-mediated, siderophore-
dependent increase in C. glabrata survival that is blunted with
increased macrophage Fe levels. Genetic manipulation of
macrophage Fe status to parallel that which is observed in human
diseases of Fe overload revealed an inverse correlation between
macrophage Fe and C. glabrata dependence on siderophore-Fe as
indicated by yeast survival rates as well as by SIT1 expression in
the macrophage phagosome. Consistent with this, infection of
primary macrophages derived from a mouse model of Ferroportin
disease in which macrophage Fe levels are chronically elevated
demonstrated enhanced C. glabrata survival that is independent of
Sit1-mediated siderophore utilization. These observations are
consistent with reports of greater microbial burden in patients with
Fe overload disease [15,18,19,20,21] and predict that mutations
affecting macrophage Fe levels may not only compromise
microbial containment, but may also dictate the dependence of
microbes on distinct mechanisms of Fe uptake.
Results
The Candida glabrata genome encodes a single
siderophore transporter
Fe acquisition is a critical microbial virulence determinant due
to the Fe-restricted nature of the mammalian host. The great
majority of body Fe is compartmentalized within red blood cells
bound as heme to hemoglobin. Several microorganisms, including
C. albicans, can access this rich Fe source by secreting hemolytic
factors that results in red blood cell lysis [22]. Heme can then be
taken up, often by means of a dedicated receptor (such as Rbt5
and Rbt51 in C. albicans [12]) and the porphyrin ring hydrolysed
by intracellular heme oxidases [23]. To test whether red blood
cells represent an efficient source of Fe for C. glabrata, we grew the
wild type strain as well as that of C. albicans and S. cerevisiae,o n
sheep blood agar plates containing 5% whole blood. Formation of
a hemolytic halo surrounding yeast colonies was evaluated after
48–72 hours growth at 30 uCo r3 7uC with 5% CO2. Unlike the
robust growth and associated hemolytic activity observed for C.
albicans, C. glabrata and S. cerevisiae displayed very weak hemolysis
when grown on blood sheep agar (Figure 1A). Furthermore,
whereas C. albicans was able to efficiently utilize heme as a source
of Fe at sub-micromolar hemin concentrations, C. glabrata required
100-fold higher hemin concentrations to achieve the same level of
growth. In the same way, higher hemin concentrations were
required for a slower growth of C. glabrata due to hemin toxicity
when compared to C. albicans (Figure 1B). The observed
differences in growth when heme is the sole Fe source may due
to the absence of an identifiable heme receptor in the C. glabrata
Author Summary
Candida glabrata is a major human pathogen due to its
low susceptibility to conventional antifungal drugs and the
dramatic increase in the number of immunocompromised
individuals suffering from HIV AIDS, cancer, and diabetes.
Iron overload is one of the most common genetically
inherited diseases and reports suggest increased suscep-
tibility of these patients to bacterial infection. The ability of
microorganisms to obtain iron from their environment is a
major determinant in their fitness and hence in their ability
to cause infectious disease. Here we demonstrate that the
siderophore iron carrier is critical for C. glabrata survival
after ingestion by mouse and human macrophage
immune effector cells. Through the generation of macro-
phage models of human iron overload disease we
demonstrate that ingested C. glabrata cells sense altered
macrophage iron levels, and that the Sit1 siderophore-iron
transporter functions as a critical determinant in the ability
of C. glabrata to survive macrophage killing in a manner
that is dependent on macrophage iron status. Our results
reveal a role for siderophore-iron as a source of iron during
C. glabrata infection, suggest additional therapeutic
intervention strategies, and support a pivotal contribution
for a common human iron overload disease in the
mechanisms used for Fe acquisition in C. glabrata.
Siderophores Promote C. glabrata Survival
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albicans and C. glabrata were cultured in Fe-deficient medium
supplemented or not with 20 mM zinc protoporphyrin (ZPP) for 3
hours. In contrast to heme, which is non-fluorescent due to the
quenching of the intrinsic porphyrin fluorescence by Fe, ZPP
fluoresces and its cellular uptake can be evaluated by in vivo
microscopy. Figure 1C shows that in contrast to C. albicans that
showed intense intracellular fluorescence, this was not observed for
C. glabrata, the intracellular fluorescence of which did not rise
above background as determined by comparison to the signal
obtained by growth under Fe deficiency alone. This suggests that
C. glabrata is not capable of taking up heme. Thus, given its weak
hemolytic activity and inability to efficiently import heme, we
predict that C. glabrata relies primarily on circulating host Fe
sources to satisfy its requirements for Fe.
Analysis of the Candida glabrata genome [24] predicts the
existence of orthologues to the Saccharomyces cerevisiae high affinity
reductive Fe assimilation pathway as well as a single open reading
frame, CAGL0E04092g, encoding a predicted membrane protein
with 14 transmembrane domains and a high degree of identity
(72%) to the siderophore-Fe transporter, Arn1, that we have
designated SIT1 (Siderophore Iron Transporter 1) (Figure 2A and
Figure S1A). Computational topological analyses of Sit1
identified sequence signatures characteristic of members of the
Major Facilitator Superfamily of transporters (data not shown). In
addition, Sit1 orthologues predicted to exist across the ascomyce-
tes, and to lesser extent basidiomycetes, share high sequence
identity within the carboxyl terminus of the protein. Protein
BLAST analysis [25] of a 51 amino acid sequence comprising the
last extra-cellular loop (from amino acid residue 531 to 581)
exclusively returned known siderophore transporters and unchar-
acterized proteins predicted to encode fungal siderophore
transporters (data not shown). This SIderophore Transporter
Domain (SITD) is conserved in many pathogenic fungi
(Figure 2A).
Sit1 mediates siderophore-Fe utilization under
conditions of Fe deficiency
To investigate the effects of Fe availability on SIT1 expression,
C. glabrata was grown under conditions of Fe-repletion or Fe-
deficiency. Figure 2B shows that steady state SIT1 mRNA levels
are elevated under Fe deficiency and that this elevation is sustained
throughout the time-course of the experiment over 6 hours. To
analyze the levels of Sit1 protein as a function of Fe availability, a
Flag epitope was introduced at the carboxyl terminus of SIT1 and
the fusion gene, encoding a functional protein, was integrated at
the endogenous SIT1 genomic locus (Figure S1B). Similar to
what was observed for SIT1 mRNA, Sit1Flag fusion protein
expression is low under Fe repletion but robustly accumulates
under conditions of Fe deficiency (Figure 2C).
Figure 1. Heme is an inefficient source of Fe for C. Glabrata.AHemolytic activity of Candida albicans, C. glabrata and S. cerevisiae. Wild type
strains were streaked onto 5% blood sheep agar plates and grown at 30 uCo r3 7uC with 5% CO2 for 48–72 hours. B Heme does not efficiently
promote the growth of C. glabrata under Fe deficiency. Candida albicans, C. glabrata and S. cerevisiae were grown in Fe-deficient medium
supplemented with the indicated concentrations of hemin and growth determined after 12 hours. C Candida albicans and C. glabrata were grown
under Fe deficiency supplemented or not with 20 mM Zn-PPIX for 3 hours and observed by live fluorescence microscopy.
doi:10.1371/journal.ppat.1001322.g001
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PLoS Pathogens | www.plospathogens.org 3 March 2011 | Volume 7 | Issue 3 | e1001322Figure 2. SIT1 substrate specificity and regulation under Fe deficiency.ASchematic illustration of the predicted Sit1 topological features. Blast
analyses of the carboxyl-terminal loop identified this conserved region as a SIderophore Transporter Domain (SITD). B RNA blot showing elevated
steady-state levels of SIT1 mRNA under Fe deficiency at the time points indicated after chelation of extracellular Fe with BPS. C. Accumulation of
Sit1Flag protein levels at the indicated time points following the addition of BPS. D Spot assays showing compromised growth of yeast strains under
Fe limitation in the absence of substrate siderophores. All siderophores were used at a concentration of 10 mM and BPS was added at a concentration
of 100 mM. E Sit1 is localized to the plasma membrane under Fe deficiency. Indirect immunofluorescence microscopy showing the accumulation of
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isms and is a major mechanism of Fe solubilization and
acquisition. The very high Fe-binding constants observed for
siderophores of fungal origin (approximately 10
30 M at pH 7) are
several orders of magnitude higher than that of the Fe
2+ chelator
BPS, which inhibits the Fet3/Ftr1 pathway of Fe
2+ uptake. We
reasoned that if a siderophore biosynthetic pathway exists in this
microorganism, C. glabrata would exhibit growth in the presence of
BPS. As shown in Figure 2D, growth of the wild type strain was
severely compromised in Fe-deficient medium chelated with 100
mM BPS. This is consistent with a predicted lack of siderophore
biosynthetic machinery in C. glabrata based on the absence of
identifiable orthologues to the gene encoding ornithine-N
5-
oxygenase that catalyses the first committed step in fungal
siderophore biosynthesis (the DNA and protein sequences of the
Aspergillus nidulans ornithine-N
5-oxygenase SidA were used to
perform the BLAST analyses) [26]. To address the role of the Sit1
transporter in xenosiderophore utilization, a mutant lacking the
SIT1 gene, as well as the reconstituted strain in which the wild type
SIT1 gene was integrated in the sit1D strain at the endogenous
genomic locus, were generated and evaluated for growth in Fe-
deficient medium alone or in the presence of several structurally
distinct fungal and bacterial siderophore substrates. Supplemen-
tation of Fe-deficient media with the fungal hydroxamate-type
siderophores ferrichrome, ferrirubin or coprogen promoted robust
growth of the wild type and SIT1-reconstituted strains
(Figure 2D). In contrast, the sit1D mutant strain was unable to
use siderophore-Fe, strongly supporting the notion that Sit1 is a
siderophore transporter capable of utilizing these xenosidero-
phores. Neither the ester-linked siderophore triacylfusarine C, nor
the bacterially-derived siderophores enterobactin, salmochelin,
yersiniabactin or desferrioxamine were able to complement the
growth of C. glabrata under iron deficiency (Figure S1C)
suggesting that these siderophores are either not transported by
Sit1 or C. glabrata lacks a mechanism of releasing the Fe from these
siderophores intracellularly.
The subcellular localization of Sit1 was evaluated using the
Sit1Flag and Sit1mCherry fusion proteins. Previous studies in S.
cerevisiae have shown that during Fe deficiency the Arn1 side-
rophore transporter is not localized to the plasma membrane but
rather to intracellular endosomal vesicles [27]. Trafficking of Arn1
to the plasma membrane is a substrate-dependent process that
occurs in a dose-dependent manner [28,29]. In contrast to this,
indirect immunofluorescence as well as live microscopy of C.
glabata Sit1 revealed strong accumulation of the Sit1 protein at the
plasma membrane under Fe deficiency in the absence of
siderophore substrate and this accumulation was largely unaltered
by the addition of ferrichrome (Figure 2E and Figure S1D).
Siderophore utilization is functional under Cu deficiency
High-affinity elemental Fe uptake requires the activity of the
Fet3/Ftr1 ferroxidase/permease complex, with the protein
complex assembled in the ER and 4 Cu ions loaded onto Fet3
within the Golgi. Under Cu deficiency, apo-Fet3-Ftr1 is assembled
and targeted to the plasma membrane, but the absence of
ferroxidase activity abolishes high-affinity Fe
2+ transport through
Ftr1 [30]. As such, elemental Fe uptake is a copper-dependent
mechanism. In contrast, siderophore transporters are not known
to require Cu for activity and would be predicted to be functional
under low Cu conditions. Figure 2F shows that siderophore
utilization is functional under Cu deficiency as imposed by growth
in the presence of the Cu chelator BCS suggesting that Fe-
siderophore transport is likely to be critical as the sole mechanism
of high affinity Fe acquisition under conditions of Cu deficiency.
Sit1-mediated siderophore utilization enhances the
survival of C. glabrata to macrophage killing
The ability of C. glabrata to exploit local xenosiderophore
reservoirs in the absence of an endogenous siderophore biosyn-
thetic pathway suggests a selective advantage imparted by this
mechanism of Fe uptake that may impact on the survival of this
fungal pathogen. Fe acquisition is challenging within the
mammalian host, in which Fe is tightly bound to proteins and
ligands in extracellular and intracellular environments. The
further active depletion of Fe from the phagosomal compartment
amplifies the microbicidal potency of macrophages as microor-
ganisms defend themselves from ROS under conditions that are
expected to compromise ROS-detoxifying enzyme activity. We
tested whether Fe deficiency would increase the susceptibility with
which C. glabrata resists macrophage killing and if this might be
circumvented by exposure of C. glabrata to substrate siderophore.
Using the mouse macrophage-like cell line, J774A.1, isogenic wild
type, sit1D and sit1D::SIT1 C. glabrata strains were grown under Fe
limiting conditions and briefly incubated in the absence or
presence of ferrichrome prior to co-culture with activated
macrophages (Figure 3A). C. glabrata cells were recovered by cell
lysis and survival was evaluated by quantitating colony forming
units (CFU) and comparing percentage yeast survival relative to
the wild type strain grown under Fe deficiency (represented by a
dashed line). Figure S2A shows that when C. glabrata cells were
grown under Fe deficiency prior to macrophage infection,
differences were not observed in the survival of the three strains
to macrophage killing. However, growth of both the wild type and
reconstituted sit1D::SIT1 strains in the presence of ferrichrome
significantly increased survival when compared to the sit1D strain,
indicative of enhanced C. glabrata ability to survive macrophage
killing as a result of siderophore-Fe utilization (Figure 3B, left
columns). This suggests that Sit1-mediated ferrichrome utilization
provides a survival advantage to phagocytosed C. glabrata cells that
is not observed in the strain that cannot internalize this Fe source.
To address whether the decreased survival of the sit1D strain could
be attributed to altered levels of phagocytosis of the mutant yeast
cells rather than decreased Fe satiety, CFU were monitored 2
hours post-infection and no significant differences between the
wild type, sit1D and sit1D::SIT1 strains were observed in the
presence or absence of ferrichrome, strongly suggesting equally
efficient phagocytosis of the three yeast strains by macrophages
(Figure S2A).
To test whether the Sit1-dependent increase in C. glabrata
survival in the presence of siderophore was a consequence of
macrophage Fe status, macrophages were Fe-loaded prior to
infection with the C. glabrata strains and the levels of ferritin, the
primary intracellular Fe storage protein, were evaluated by
immunoblotting. As shown in Figure S2B, activated macrophag-
es cultured under Fe supplementation (lane 4) showed higher
ferritin protein levels than those cultured in normal medium (lane
2). Under these conditions of exogenous Fe loading, differences in
survival were not observed between the wild type, sit1D and
Sit1Flag at the plasma membrane under Fe deficiency in the presence or absence of ferrichrome (FC). Ferrichrome was added to Fe-deficient yeast
cells 20–30 minutes prior to microscopic visualization F Siderophore utilization is functional under copper (Cu) deficiency. Spot assays were
performed under either Fe limitation or Cu limitation in the presence or absence of ferrichrome as indicated.
doi:10.1371/journal.ppat.1001322.g002
Siderophores Promote C. glabrata Survival
PLoS Pathogens | www.plospathogens.org 5 March 2011 | Volume 7 | Issue 3 | e1001322sit1D::SIT1 yeast strains grown in the presence or absence of
ferrichrome (Figure 3B, right columns). Furthermore, signifi-
cantly higher CFU were recovered from Fe-loaded macrophages
under all conditions tested when compared to infection of
macrophages growing in the absence of Fe supplementation,
suggesting that elevated Fe compromises the ability of macro-
phages to contain C. glabrata proliferation within the phagosome.
To ascertain whether Fe-loading compromises macrophage
activation and the ability to mount an inflammatory response,
secreted levels of TNF-alpha, an acute phase inflammatory
cytokine secreted by activated macrophages, were assayed and
no significant changes were observed between that secreted from
activated Fe-loaded macrophages and activated macrophages
cultured in standard growth media (Figure S2C).
Despite the fact that the overall mechanisms of innate and
adaptive immunity are relatively conserved between mice and
humans, there are striking immunological differences between the
two species [31]. In particular, there is some controversy over
whether human macrophages express functional inducible nitric
oxide synthase (iNOS). This enzyme catalyzes the production of
NO from L-arginine that, in the oxidative environment of the
phagosome, reacts with superoxide leading to the generation of
peroxynitrite, a powerful oxidant used by macrophages and
neutrophils in microbial killing during the oxidative burst. Given
this and other differences in mouse and human macrophage
immunobiology, we asked whether Sit1-mediated siderophore
utilization enhanced C. glabrata survival to killing by human
macrophages. To test this, we used the U937 cell line derived from
a hystiocystic lymphoma whose differentiation and activation have
been previously described [32,33]. Upon differentiation into
mature macrophages, U937 cells were infected with the wild
type, sit1D and sit1D::SIT1 C. glabrata strains grown under Fe
deficiency, with or without a brief exposure to ferrichrome, and
yeast CFU quantitated after 18, 24 and 36 hours of co-culture.
Figure 3. Macrophage Fe status determines the degree of Sit1 dependence for C. glabrata to survive macrophage killing. A Schematic
flowchart of the macrophage infection assay developed for C. glabrata virulence studies. C. glabrata cells were grown in low Fe medium for 5 hours
and pulsed with 10 mM ferrichrome (FC) for 30–45 minutes prior to exposure to activated mouse macrophages. C. glabrata cells were recovered from
the lysed macrophages, plated on YPD and colony forming units (CFU) counted after 2 days at 30 uC. Data were analyzed with use of one-way
ANOVA. B Sit1-mediated siderophore utilization enhances the survival of C. glabrata to macrophage killing activities (left columns) and this is
ameliorated by elevated intracellular macrophage Fe. Macrophages were Fe-loaded with ferric ammonium citrate [20 mM] for 2 days prior to infection
with C. glabrata. Each experiment included 6 replicates per experimental sample. Results are shown as mean survival compared to the wild type
grown in the absence of ferrichrome supplementation (dashed line) and are representative of at least 3 experiments. Bars represent standard error. C
The human monocytic cell line, U937, was differentiated into mature macrophages prior to infection with the indicated C. glabrata strains grown
under Fe deficiency without or with supplementation of 10 mM FC and yeast survival evaluated after 18, 24 and 36 hours of infection. The results
depicted show the mean survival of the wild type, sit1D and sit1D::SIT1 strains grown in the presence of FC prior to macrophage infection. Bars
indicate standard error. D U937 macrophages were Fe-loaded with ferric ammonium citrate [20 mM] for 2 days prior to infection with C. glabrata
strains grown under Fe deficiency without or with supplementation of 10 mM FC and yeast survival evaluated after 18, 24 and 36 hours of infection, as
described above.
doi:10.1371/journal.ppat.1001322.g003
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and SIT1 reconstituted strains displayed enhanced survival at all
time points in contrast to the sit1D mutant strain that is unable to
transport the siderophore. Pre-loading U937 cells with Fe by
culturing in the presence of 20 mM FAC promoted the growth of
C. glabrata and abrogated the requirement for Sit1-mediated
siderophore utlization in enhanced C. glabrata survival
(Figure 3D). These results recapitulate the observations made
in the J744A.1 mouse macrophage cell line and suggest that Sit1-
mediated siderophore utilization protects C. glabrata against the
intracellular microbicidal activities of macrophages. Given the
generation of ROS in the phagosome of activated macrophages
(Figure S2D), indicative of higher levels of oxidative stress, we
hypothesize that siderophore-Fe plays a role in providing the Fe
required for DNA replication and cellular proliferation as well as
for defence against oxidative stress. Moreover, these results
indicate that macrophage Fe-withholding from phagocytosed
microorganisms is fundamental for the containment of microbial
growth and also impacts on the mechanisms available for
microbial iron uptake, imposing a strict dependence of C. glabrata
on the availability and utilization of xenosiderophores via Sit1.
Macrophage Fe status dictates the dependence of
C. glabrata on Sit1 function
Based on the effect of macrophage Fe loading on C. glabrata Sit1-
mediated siderophore-dependent survival, we asked whether
mutations that alter macrophage Fe homeostasis might similarly
modulate the dependence of C. glabrata on siderophore-Fe
acquisition. The sole mammalian Fe exporter Fpn is expressed on
the surface of enterocytes, macrophages, hepatocytes and placental
cells where it plays a fundamental role in systemic Fe homeostasis.
Type IV hemochromatosis, or Ferroportin disease, is an autosomal-
dominant condition that arises from missense mutations in Fpn that
compromise regulated Fe export activity. Two often contrasting
clinical presentations observed in patients result from distinct
mutations in Fpn that either abolish the hepcidin binding site or
compromise Feexport, leadingto differentialeffects onmacrophage
Fe levels [16,34,35,36]. We modulated macrophage Fe status by
stably expressing a cDNA encoding the FPN
C326Y hepcidin-
insensitive disease mutation, associated with low macrophage Fe
levels, or the FPN
H32R allele identified in the flatiron mouse that fails
to localize to the plasma membrane, leading to Fe-overload. Using
ferritin protein levels as a biomarker of macrophage Fe loading,
macrophages expressing the FPN
H32R transgene were chronically
iron-loaded in the absence of hepcidin when compared to
macrophages expressing the wild type gene due to the loss in
ability to export cellular Fe (Figure 4A, lanes 1 and 3). Incubation
with hepcidin increased ferritin levels in cells expressing wild type
FPN, as would be predicted from Fpn internalization and
degradation, resulting in increased cellular Fe accumulation
(Figure 4A, lane 2). In contrast, hepcidin had only a mild effect
on FPN
H32R-expressing macrophages (Figure 4A, lane 4). Given
that Fpn functions as a dimer [37], this modest increase in ferritin
levels may reflect the contribution of hepcidin-sensitive endogenous
wild type homodimers that correctly localize to the plasma
membrane. In contrast, macrophages expressing the FPN
C326Y
transgene show lower than wild type ferritin levels when grown
under Fe-replete conditions in the presence of hepcidin, consistent
with a chronic Fe efflux under conditions that induce Fpn turnover
of the wild type protein (Figure 4B, lanes 2 and 4). Indirect
immunofluorescence in macrophages expressing the wild type and
mutant FPN transgenes was performed to monitor protein
localization. Both the wild type and Fpn
C326Y-expressing cells, but
not cells expressing Fpn
H32R, show plasma membrane ferroportin
accumulation in the absence of hepcidin (Figure S3A). Exposure to
hepcidin leads to a predominantly intracellular localization of the
wild type protein, whereas the hepcidin-insensitive Fpn
C326Y
protein remains at the cell surface.
Using these macrophages with altered Fe homeostasis, we
ascertained whether genetically programmed differences in
macrophage Fe levels impinge on the dependence of C. glabrata
on siderophore-Fe for resistance to macrophage killing activities.
Macrophages stably expressing the wild type and mutant forms of
FPN were infected with wild type, sit1D and the SIT1-reconstituted
C. glabrata strains that had been grown under Fe deficiency and
exposed or not to ferrichrome. As shown in Figure 4C, wild type
and SIT1-reconstituted C. glabrata yeast cells, but not sit1D cells,
showed enhanced survival to macrophages expressing wild type
Fpn only when grown in the presence of ferrichrome prior to
infection, as interpreted from the increased number of CFU when
compared to the wild type C. glabrata strain grown in the absence
of FC (dashed line set at 100). No differences were observed in the
survival of the three C. glabrata strains grown in the absence of
ferrichrome supplementation (data not shown). This recapitulates
the results obtained in non-transfected J774A.1 mouse macro-
phages and human differentiated U937 cells in the absence of Fe
supplementation (Figure 3B, left columns). In contrast, side-
rophore-dependent differences in C. glabrata survival were not
observed between the yeast strains recovered from the chronically
Fe-loaded macrophages expressing the FPN
H32R transgene,
supporting our previous results using exogenously Fe-loaded
macrophages (Figure 3B, right columns). This is consistent with
the high levels of labile intracellular Fe in FPN
H32R macrophages
that elevate the abundance of ferritin and might be inefficiently
withheld from C. glabrata. In contrast, C. glabrata recovered from
FPN
C326Y macrophages cultured in the presence of hepcidin
exhibit increased dependence on siderophore-Fe utilization for
survival when compared to those recovered from macrophages
expressing wild type Fpn (Figure 4D). This is consistent with the
refractility of Fpn
C326Y to hepcidin-stimulated degradation and Fe
levels in these macrophages that are lower than wild type. To
ascertain whether Fe overload or deficiency might compromise the
ability of macrophages to mount an inflammatory response, the
levels of TNF-alpha were quantified from the culture medium of
activated macrophages expressing the FPN, FPN
C326Y and
FPN
H32R transgenes and no difference was found between cell
lines (Figure S3B). Taken together, these data suggest that
elevated macrophage Fe accumulation increases Fe accessibility to
internalized C. glabrata. This ameliorates the strict requirement for
Sit1-mediated siderophore utilization observed in macrophages
with limited intracellular Fe.
Macrophage Fe status modulates the expression of
C. glabrata SIT1
The results presented here suggest that Sit1-dependent side-
rophore utilization enhances C. glabrata survival to activated
macrophages in a manner that is dependent on macrophage labile
Fe status. SIT1 characterization demonstrated that expression is
responsive to environmental Fe bioavailability, showing low levels
of expression under Fe repletion and robust mRNA and protein
accumulation under Fe deficiency (Figure 2B and 2C). Using a
reporter strain expressing a SIT1mCherry fusion gene from the
endogenous SIT1 locus, we ascertained whether internalized C.
glabrata cells sense differences in genetically-programmed macro-
phage Fe status. As shown in Figure 5A by live microscopy, C.
glabrata cells phagocytosed by macrophages expressing the
FPN
C326Y transgene showed enhanced Sit1mCherry accumulation
when compared to yeast internalized by macrophages that were
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H32R expression, suggesting that C.
glabrata cells experienced different degrees of Fe deficiency in these
macrophages. Fluorescein-conjugated dextran beads were includ-
ed in the infection medium to allow for a clearer visualization of
intra- versus extra-cellular yeast. To quantitatively evaluate the
influence of macrophage Fe status on the Fe satiety of C. glabrata,
SIT1 transcript levels were monitored in yeast cells recovered from
macrophages by semi-quantitative RT-PCR. Figure 5B shows
that cells recovered from FPN
H32R-expressing macrophages
exhibited lower levels of the SIT1 transcript when compared to
cells recovered from FPN
C326Y-expressing macrophages two and
four hours post-infection, consistent with an increased Fe satiety
within the phagosome. These results support the hypothesis that
chronic perturbations in macrophage Fe levels translate into
altered microbial Fe availability that may impact on the
mechanisms of microbial Fe uptake.
Ex-vivo infection of mouse primary macrophages
supports a critical role for macrophage Fe loading on the
dependence of C. glabrata on Sit1-mediated siderophore
utilization
Given the effects of macrophage Fe status on the dependence of
C. glabrata siderophore utilization using well-established macro-
phage cell lines, we ascertained whether this could be recapitulated
in an ex-vivo infection of primary mouse macrophages. Bone
marrow cells were recovered from the femurs of control mice and
of the flatiron (ffe) mouse model of human Ferroportin Disease,
which harbors the FPN
H32R mutation [36]. Cells were differenti-
ated into mature macrophages in culture and endogenous Fpn
expression stimulated by incubating cells in 10 mM ferric
ammonium citrate for 2 days prior to activation and infection
with C. glabrata (Figure 6A). Consistent with the results obtained
using the J774A.1 and U937 cell lines, when grown in the presence
Figure 4. Macrophage models of Fe homeostasis disease modulate survival of C. glabrata and dependence on siderophore Fe. A
J774A.1 cells stably expressing FPN
H32R are chronically Fe-loaded. J774A.1 stably expressing either wild type FPN or FPN
H32R were grown in the
presence or absence of hecidin for 24 hours. Intracellular labile Fe levels were monitored by evaluating H- and L-ferritin levels through
immunoblotting. B J774A.1 cells expressing FPN
C326Y are compromised for Fe accumulation in the presence of hepcidin. J774A.1 stably expressing
either wild type FPN or FPN
C326Y were grown in the presence or absence of hepcidin for 24 hours. Intracellular Fe status was monitored by evaluating
H- and L-ferritin levels. C Dependence on Sit1-mediated siderophore utilization for C. glabrata survival is reduced in macrophages expressing FPN
H32R.
Stable cell lines expressing the wild type and FPN
H32R allele were infected with C. glabrata and CFU quantitated after 18–24 hours of co-culture.
Results are shown as survival relative to wild type C. glabrata grown under Fe deficiency represented by a dashed line. Data were analyzed with use of
one-way ANOVA. D Hepcidin insensitivity of the iron-deficient FPN
C326Y allele imposes a greater dependence on siderophore-Fe when compared to
the more Fe-loaded macrophages expressing the wild type FPN allele. Stable cell lines expressing the wild type and FPN
C326Y allele grown in the
presence of hepcidin were infected with C. glabrata and CFU counted. Results are shown as survival relative to wild type C. glabrata grown under Fe
deficiency represented by a dashed line. Each experiment included 6 replicates per experimental sample. Results are shown as mean survival
compared to the wild type grown in the absence of ferrichrome supplementation and are representative of at least 3 experiments. Bars represent the
standard error. Data were analyzed with use of one-way ANOVA.
doi:10.1371/journal.ppat.1001322.g004
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showed enhanced survival to the killing activities of wild type
primary macrophages when compared to the sit1D strain
(Figure 6B). However, siderophore-dependent survival was
significantly diminished in infected ffe macrophages, supporting
our previous observations that increased macrophage labile Fe
pools promote the growth of C. glabrata independently of
siderophore utilization.
Integrity of the Sit1 SITD is critical for ferrichrome
utilization
Computational analysis of the Sit1 SITD (Figure 2A) revealed
a high degree of conservation among orthologous siderophore
transporters in a large number of fungal species, including several
animal and plant pathogens, a representative number of which are
shown in Figure S4. To begin to evaluate a potential role for the
SITD in Sit1-mediated siderophore utilization in C. glabrata, the
predicted extracellular topological orientation of the carboxyl-
terminal loop between transmembrane domains 13 and 14 was
first evaluated experimentally. Sit1 was tagged with a 2XFLAG
epitope within the carboxyl-terminal loop between residues G542
and D543 (Figure S5A). Cells expressing this tagged Sit1 protein,
or the empty vector, were cultured under Fe deficient conditions
and the accessibility of the anti-Flag antibody for its cognate
epitope evaluated in non-permeabilized cells by indirect immu-
nofluorescence. As shown in Figure S5B, plasma membrane
accumulation of the Flag antibody was observed in non-
permeabilized cells expressing carboxyl-loop-Flag Sit1. This
immunofluorescence signal was absent in cells expressing vector
alone and is consistent with an orientation of this loop region, and
therefore the SITD, toward the extracellular face of the plasma
membrane.
To test whether the Sit1 SITD may be of functional
importance, we mutated the conserved residue, Y575 to alanine
(Figure S4), and tested whether this might compromise Sit1-
mediated ferrichrome utilization. A strain carrying the SIT1
Y575A
allele integrated at the endogenous genomic locus (Figure S5C)
was strongly impaired in its ability to use ferrichrome as an Fe
source (Figure 7A) despite exhibiting levels of protein expression
(Figure S5D) and plasma membrane localization (Figure 7B
and Figure S5E) comparable to the wild type strain. The
observed decrease in the ability of the Sit1
Y575A mutant to utilize
ferrichrome prompted us to evaluate the ability of this strain to
survive macrophage killing when grown in the presence of this
siderophore. In contrast to wild type C. glabrata cells, neither the
sit1D nor the strain bearing the Sit1
Y575A substitution in Sit1
showed the Sit1-mediated siderophore-dependent increase in the
ability to survive macrophage killing, suggesting that although this
mutation does not lead to a complete loss of Sit1 function (see
Figure 7A), the remaining activity is insufficient to meet the
cellular demand for Fe within the phagosome (Figure 7C).
Discussion
Candida glabrata has risen from relative obscurity as a relevant
opportunistic human fungal pathogen to an increasing cause of
Figure 5. C. glabrata is responsive to host intracellular labile Fe pools. A J774A.1 cells expressing the mutant FPN transgenes were infected
with the C. glabrata SIT1mCherry strain reporter and visualized upon co-culture for 8 hours using live microscopy. Fluorescein-conjugated dextran
beads were added prior to co-culture to ascertain whether yeast cells were located intracellularly rather than on the surface of macrophages. B
Macrophage Fe overload is associated with increased C. glabrata Fe satiety whereas the severe macrophage Fe depletion associated with Fpn
C326Y
leads to elevated SIT1 expression. C. glabrata cells were recovered from infected macrophages at the indicated time points and the levels of SIT1
mRNA quantified by RT-PCR. Each experiment included 3 replicates per experimental sample. Bars represent the standard error.
doi:10.1371/journal.ppat.1001322.g005
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individuals. Yet, the significant phylogenetic relatedness of C.
glabrata to Saccharomyces cerevisiae argues for some fundamental
differences in the biology of this microorganism, either through the
functions of the as yet poorly studied 400 genes unique to Candida
glabrata and/or through the enhancement or acquisition of novel
functions of shared genes. Our results underscore a role for
siderophore utilization in the successful existence of C. glabrata as a
human commensal as well as during pathogenesis, primarily with
respect to survival to phagocytosis by mammalian macrophages.
Furthermore, our studies support a pivotal contribution for
unregulated host Fe acquisition in the outcome of fungal infection.
The severe Fe restriction imposed by mammalian hosts as an
antimicrobial strategy dictates that Fe acquisition is a bona fide
virulence determinant. The existence of clinical correlations
between elevated Fe bioavailability and increased microbial
burden extend beyond diseases of Fe overload for which the
higher susceptibility to bacterial infection, notably to Vibrio
vulnificus, has been described [15,18]. In the same way,
transfusion-dependent thalassemia patients present with increased
susceptibility to widespread microbial infection that correlates with
the degree of Fe overload [19]. Treatment of HH and thalassemia
patients is further complicated by the fact that the sole FDA-
approved Fe chelator desferrioxamine, a naturally occurring
bacterial siderophore, effectively further solubilises Fe in a form
that is readily utilized by a diversity of bacterial and fungal species,
thus elevating the potential for infectious disease in these patients.
Individuals with malignant hematological disorders, such as acute
myeloid leukemia, who typically present with very high serum Fe,
serum ferritin and transferrin saturation, are known to sustain
increased mycoses, especially by Candida and Aspergilli [38,39].
Furthermore, clinical evidence also indicates that Fe overload is an
independent risk factor for post-transplant infection [20,21] and
correlates with poor prognosis and in patients infected with HIV, a
virus known to depend on and manipulate target cellular Fe
accumulation [40]. What then are the implications of Fe overload
diseases to the susceptibility to fungal infections? Previous studies
support the notion that optimal immunity operates within a range
of physiological Fe concentrations [41]. This is ensured in part
through Fpn activity, mobilizing dietary and systemic Fe, and the
Figure 6. C. glabrata shows Sit1-dependent siderophore utilization in primary macrophages derived from wild type but not the
flatiron mouse. A Schematic flowchart for infection of primary mouse macrophages with C. glabrata. Primary macrophages were differentiated from
bone marrow cells harvested from control and flatiron mice, infected with the wild type, sit1D and reconstituted sit1D::SIT1 C. glabrata strains and
CFU quantitated. Fe was added to the macrophage culture medium to stimulate FPN expression and cells were washed 3 times prior to infection with
yeast strains. Data were analyzed with use of one-way ANOVA. B Infection of control primary bone marrow macrophages with C. glabrata showed
robust Sit1-dependent survival with ferrichrome supplementation when compared to wild type C. glabrata grown exclusively under Fe deficiency
(dashed line set at 100). This siderophore-dependent enhanced survival was absent in C. glabrata cells phagocytosed by primary macrophages
derived from the flatiron mouse. Each experiment included 6 replicates per experimental sample. Results are shown as mean survival compared to
the wild type grown in the absence of ferrichrome supplementation and are representative of at least 3 experiments. Bars represent the standard
error.
doi:10.1371/journal.ppat.1001322.g006
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presents with different genetic etiologies that impart distinct effects
on macrophage Fe levels. Using mutations associated with
Ferroportin Disease, an autosomal dominant disease in humans,
we provide evidence that C. glabrata dependence on the side-
rophore-Fe uptake machinery is inversely correlated to labile
macrophage Fe levels and that Fe overloaded macrophages are
markedly less efficient at killing and containing C. glabrata. We
infer that this results from the inability of Fe-laden macrophages to
withhold this essential metal from internalized C. glabrata cells
given the decreased dependence of C. glabrata on siderophore-Fe,
decreased SIT1 expression indicative of increased Fe satiety,
increased C. glabrata fitness and the increased levels of host cell
ferritin expression. Previous studies have shown that activated
macrophages accumulate Cu within the phagosome [42] suggest-
ing perhaps that inefficiently withheld macrophage Fe can be
mobilized through reductive Fe uptake and supporting a host-
dependent modulation of high-affinity mechanisms of Fe assim-
ilation. This notion of a host modulatory action over the
mechanisms utilized for microbial Fe acquisition is further
evidenced in a study by Lesuisse [43] that compared the effects
of exposure of C. albicans to either fetal bovine serum or synthetic
Fe-deficient medium supplemented with distinct Fe sources. The
results obtained showed that reductive Fe uptake from ferric
citrate was downregulated in the presence of serum, as evidenced
by decreased Fe uptake and reduced ferrireductase activity,
whereas that from ferrichrome-type siderophores was elevated.
In contrast to Fe-loaded macrophages, the low macrophage Fe
levels associated with Fpn
C326Y expression impose Fe deficiency on
phagocytosed C. glabrata cells, as demonstrated by elevated SIT1
expression and further supported by the increased dependence on
ferrichrome and Sit1 for proliferation. As a result of chronic Fe-
deficiency, hepcidin-insensitive macrophages are expected to
represent a formidable challenge for microbial proliferation. The
FPN
C326Y disease-associated mutation results in a similar clinical
outcome to that observed in patients carrying HFE mutations
present in approximately 80% of HH patients and exhibiting an
allelic frequency of over 10% in Caucasians of European descent
[13]. Given the high prevalence of HFE mutations, it has been
postulated that this mutation was positively selected for conferring
protection during outbreaks of infections caused by intracellular
pathogens such as Chlamydia and Yersinia [44,45] highlighting the
intimate association between host Fe status and infectious disease.
Whilst siderophore utilization is also undoubtedly critical to
microbial colonization of healthy immunocompetent individuals in
its state of commensalism, our study prompts an as yet unresolved
question in the field regarding the origin of xenosiderophore
substrates that are utilized by non-siderophore producers such as
Candida and Cryptococcus species. A recent study by Ghannoum
et al. characterizing the mycobiome of the oral cavity of healthy
Figure 7. A conserved residue in the Sit1 SITD compromises ferrichrome utilization and survival in macrophages. A The Sit1
Y575A
strain is compromised in ferrichrome utilization under Fe deficiency. C. glabrata strains were grown to mid-logarithmic phase and 10-fold serial
dilutions spotted onto rich synthetic media and Fe-deficient media supplemented or not with 10 mM ferrichrome. B Sit1
Y575A localizes to the plasma
membrane. In vivo fluorescence of wild type Sit1mCherry and Sit1
Y575AmCherry strains cultured under Fe deficiency. C The Sit1
Y575A strain is
compromised the ability to use siderophores to survive macrophage killing. Activated J774A.1 cells were infected with wild type, sit1D or
sit1D::SIT1
Y575A C. glabrata strains and CFU quantitated. Results are shown as survival relative to wild type C. glabrata grown under Fe deficiency
represented by a dashed line. Each experiment included 6 replicates per experimental sample. Results are shown as mean survival compared to the
wild type grown in the absence of ferrichrome supplementation and are representative of at least 3 experiments. Bars represent the standard error.
doi:10.1371/journal.ppat.1001322.g007
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profile of fungal species, the number of which parallels that
observed for bacteria [46]. Among the fungi found to colonize the
oral cavity of humans are several siderophore-producers that
include Aspergillus and Fusarium species known to copiously produce
siderophores that include coprogens and ferrichromes, both
substrates for Sit1-facilitated utilization in C. glabrata. In particular,
Aspergillus fumigatus, one of the most prevalent air-borne human
pathogens, synthesizes chemically distinct siderophores for the
solubilization of extracellular Fe as well as for its safe intracellular
storage [47]. In fact, siderophore utilization by this saprophytic
fungus has been shown to be required for virulence, in contrast to
reductive Fe assimilation [48], and the conidia of a siderophore-
deficient mutant exhibit decreased levels of stored Fe and higher
sensitivity to oxidative stress [47]. Given the ubiquitous nature of
siderophore production and the mixed nature of the mammalian
microbiome localized siderophore reservoirs are likely available to
C. glabrata and other non-siderophore producers. In particular, it is
tempting to speculate that the higher microbial burden associated
with immunocompromised patients generates higher concentra-
tions of microbial siderophores that might tip the balance towards
the transition from commensalism to pathological C. glabrata
proliferation and subsequent infectious disease.
Given the inability of C. glabrata to efficiently use heme, Sit1-
dependent siderophore utilization represents a likely mechanism
for high-affinity Fe uptake under conditions of Cu insufficiency,
conditions under which elemental high affinity Fe uptake is
compromised. This suggests that siderophore utilization might
contribute toward the virulence of C. glabrata in both the Fe- and
Cu-restricted mammalian host [49]. Sit1 is syntenic to its
orthologous gene in S. cerevisiae, Arn1, with which it shares high
sequence identity that translates into similar siderophore substrate
specificity, which includes ferrichromes and coprogen. Yet, Sit1
and Arn1 differ in their subcellular localization. The routing of
trans-Golgi Arn1 away from the plasma membrane and to the
vacuolar protein-sorting pathway requires the monomeric clathrin
adaptor, Gga2 [50]. Given the existence of a putative orthologue
for Gga2 in C. glabrata, it is unclear whether differences in
transporter localization reflect distinct protein-protein interactions
or another mechanism of siderophore transport altogether - pore
versus receptor, for instance. Interestingly, C. albicans Sit1 as well
as S. cerevisiae Enb1 [7], also localize predominantly to the
plasma membrane in either the absence or presence of substrate
siderophore [51]. It is tempting to speculate that under the
pressure of harsh competition for Fe and local xenosiderophore
reservoirs, C. glabrata and C. albicans have evolved to become more
competitive for siderophore binding by expressing the transporter
constitutively at the cell surface. Further studies are required to
elucidate the mechanism of siderophore recognition and uptake by
Sit1 as well as its intracellular fate, an aspect of siderophore
utilization that is currently poorly understood in fungi.
Materials and Methods
Yeast strains and growth conditions
C. glabrata strains, BG2 and BG14 (ura3::KAN), were a gift from
Dr. Brendan Cormack at the Johns Hopkins School of Medicine,
Maryland. Growth under Fe-replete conditions was achieved by
supplementing media with 5 mM ferrous ammonium sulfate. Fe-
deficient media contained 100 mM bathophenantroline disulpho-
nate (BPS). For spot assays, cells were grown in synthetic complete
medium (SC) to mid-logarithmic phase and serial dilutions were
spotted on SC or SC supplemented with 100 mM BPS or 150 mM
bathocuproine sulfonate (BCS) with or without the indicated
siderophores. Ferrichrome, desferrioxamine, hemin and zinc
protophorphyrin were purchased from Sigma Aldrich, St. Louis,
MO; ferrirubin, coprogen, enterobactin, salmochelin, triacylfusar-
ine C and yersiniabactin were purchased from EMC Microcollec-
tions, Tuebingen, Germany. Alexa Fluor-conjugated dextran was
purchased from Invitrogen, Carlsbad, CA. For macrophage
infection experiments, yeast cells cultured in low Fe medium for
5 hours were exposed or not to ferrichrome [10 mM] 30–35
minutes and the yeast cultures were washed three times with PBS
prior to infection. The BG14 strain was used to generate the sit1D
strain by the PRODIGE PCR-based approach [52]. The
SIT1FLAG knock-in cassette was created by overlap PCR of the
SIT1 ORF and 964 bp upstream promoter was used to generate
the in-frame SIT1FLAG-fusion DNA subcloned upstream of the
nourseothricin resistance (NAT
R) cassette with a further 400 bp of
the SIT1 3’UTR cloned downstream of NAT
R. The sit1D::SIT1m-
Cherry strain was generated by targeted integration of a
SIT1mCherryNAT
R cassette cloned into pBM46. Generation of
SIT1 tagged with two FLAG epitopes between residues G542 and
D543 within the carboxyl-terminal loop was generated by overlap
PCR. The Sit1Y575A mutation was generated by site-directed
mutagenesis (QuikChange Site-Directed Mutagenesis Kit, Strata-
gene, La Jolla, CA) and either integrated at the endogenous
genomic locus or expressed episomally. For C. glabrata transfor-
mation, overnight cultures were transformed with 5 mg DNA using
the Frozen-EZ Yeast Transformation II Kit (Zymo Research,
Orange, CA) according to the manufacturers instructions.
Transformants were selected by growth on YPD media containing
200 mg/ml nourseothricin (Werner BioAgents, Jena, Germany) at
30 uC for 2–4 days.
RNA and protein analyses
Cells were cultured in SC containing ferrous ammonium sulfate
[5 mM] in the absence or presence of BPS [80 mM] and samples
harvested at the indicated time points and processed for RNA and
protein extraction. Total RNA was extracted using the hot acid
phenol method [53]. PCR-amplified probes were gel-purified and
radiolabeled with alpha-P
32-dCTP (GE Healthcare, Piscataway,
NJ) using Random Primed DNA Labeling Kit (Roche Applied
Science, Indianapolis, IN). Semi-quantitative PCR was performed
on cDNA generated by reverse transcription of isolated total RNA
(Superscript III first strand; Invitrogen, Carlsbad, CA) using
primers specific for SIT1 and ACT1. SIT1 expression levels were
normalized against those of ACT1. Total protein was extracted in
ice-cold lysis buffer (Tris 25 mM, pH7.5, NaCl 150 mM, 1 mM
EDTA) supplemented with protease inhibitors (Roche complete
tablet; Roche Applied Science, Indianapolis, IN) using the Triton
X-100/glass bead method and total protein quantified using BCA
reagent (Pierce, Rockford, IL). Sit1Flag was detected using an
HRP-conjugated a-Flag antibody (Sigma Aldrich, St. Louis, MO).
An alpha-Pgk1 antibody was used as loading control.
Fluorescence and indirect immunofluorescence
microscopy
The sit1D::SIT1mCherry cells were visualized with a Zeiss Axio
Image widefield fluorescence microscope. In vivo visualization of
macrophages infected with C. glabrata strain sit1D::SIT1mCherry was
performed using a Zeiss Axio Observer Z1 fluorescence micro-
scope. Indirect immunofluorescence of Fpn was observed and
captured using a motorized Zeiss Axio Observer Z1. Cells were
fixed in methanol at 220 uC for 5 minutes, incubated with Fpn
antibody (a gift from Drs. Jerry Kaplan and Ivana de Domenico,
University of Utah) and incubated with a secondary fluorochrome-
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gen, Carlsbad, CA).
ROS measurement
J774A.1 macrophages seeded at 2610
5 cells/ml were activated
with 1 mg/ml LPS and 5 ng/ml LPS for 3 hours and 2 mM2 9,7
dichlorofluorescein diacetate (DCFH-DA) added during the last 15
minutes. Fluorescence was monitored 450 nm excitation and
530 nm emission using a fluorescence plate reader (Perkin-Elmer
1420 Victor 3).
Mammalian cell infection assay
The mouse macrophage cell line J774A.1 was maintained in
Dulbecco’s Modified Eagles Medium 4.5 g/L D-glucose (Gibco,
Invitrogen, Carlsbad, CA), 10% FBS, 100U penicillin and 100 mg/
ml streptomycin, at 37 uC and 5% CO2. For iron loading
experiments, J774A.1 macrophages were cultured in 20 mM ferric
ammonium citrate for 2 days and washed 3 times with warm
DMEM prior to infection with C. glabrata. Macrophages seeded at
2610
5 cells/ml overnight were activated with IFN-gamma [5 ng/
ml] (Sigma Aldrich, St. Louis, MO) and LPS [1 mg/ml] (Sigma
Aldrich, St. Louis, MO) 3 hours prior to infection with C. glabrata
strains at a multiplicity of infection of 1:4 (macrophage:yeast). At the
indicated time points infected macrophages were lysed with water,
and dilutions of the lysates plated on YPD. Colony forming units
(CFU) were counted after growth at 30 uC for 2 days. U937 cells
were maintained in RPMI-1640 medium (Gibco, Invitrogen,
Carlsbad, CA), supplemented with 2 mM glutamine, 10% FBS,
100U penicillin and 100 mg/ml streptomycin, at 37 uCa n d5 %
CO2. Differentiation of these pro-monocytic cells into mature
macrophages was induced by the addition of 10 nM phorbol
myristate acetate (PMA) to 1610
6 cells/ml for 48 hours. Cells were
washed 3 times with warm culture medium and incubated for a
further48 hours at 37 uC and 5%CO2. LPS (1 mg/ml) was added to
the macrophages 3 hours prior to infection with C. glabrata (MOI of
1:1) and yeast cell recovery and CFU counting performed as
described above. For primary macrophage infection assays, mouse
femurs were kindly supplied to us by Drs. Jerry Kaplan and Ivana
De Domenico, at the University of Utah. Primary bone marrow
cells were harvested by flushing the femurs of 3–5 month-old female
control (C3H) or flatiron (ffe) mice and macrophage differentiation
induced by culturing in RPMI1640 containing 20% FBS, 20 mMß -
mercaptoethanol, 2 mM L-glutamine, 100U penicillin and
100 mg/ml streptomycin and GM-CSF [3 ng/ml]. Macrophages
were seeded for infection assays at 2610
5 cells/ml.
For the generation of stable cell lines expressing wild type and
mutant forms of FPN, full-length mouse FPN cDNA (TrueORF,
OriGene, Rockville, MD) was used as a template to introduce the
H32R and C326Y mutations through site-directed mutagenesis.
FPN, FPN
H32R and FPN
C326Y plasmid DNA were stably transfected
into J774A.1 macrophages using Lipofectamine reagent (Invitro-
gen, Carlsbad, CA). Total protein was extracted in lysis buffer as
described above supplemented with 0.1% SDS and a phosphatase
inhibitor cocktail (HALT, Pierce, Rockford, IL). Antibodies
against ferritin and a-tubulin were purchased from Abcam
(Cambridge, MA). IL-6 and TNF-alpha secretion was measured
by enzyme-linked immunosorbent assay (ELISA) (R&D Systems,
Minneapolis, MN). Fluorescence was measured using a Spectra-
Max Plus luminometer (Molecular Devices, Sunnyvale, CA).
Accession numbers
The SIT1 DNA, protein sequence and functional description
were deposited in GenBank with the Accession Number
HQ734814.
Supporting Information
Figure S1 Complementation assays showing the functionality of
the C. glabrata Sit1 Sit1mCherry and Sit1Flag fusion proteins. A.
Alignment of C. glabrata Sit1 and S. cerevisiae Arn1 protein sequences.
The protein sequences of S. cerevisiae Arn1 and C. glabrata Sit1 were
aligned using ClustalW. B. The Sit1mCherry and Sit1Flag fusion
proteins are functional for siderophore utilization. The fusion genes
were each independently integrated back into the sit1 D strain at the
endogenous genomic locus and functionality confirmed by growth
on low Fe media supplemented with ferrichrome. C. Sit1 is unable
to facilitate the utilization of the bacterial siderophores desferriox-
amine (DFO), enterobactin (EB), salmochelin (S4) or yersiniabactin
(YB) or the fungal siderophore triacetylfusarine C (TAFC). C.
glabrata strains were grown to mid-logarithmic phase and serial
dilutions were spotted onto rich synthetic media and Fe-deficient
media supplemented or not with the indicated siderophores.
Ferrichrome was used at a concentration of 10 mM and BPS was
added at a concentration of 100 mM. All other siderophores were
used ata concentrationof50 mM.D.Plasmamembranelocalization
of Sit1mCherry using in vivo immunofluorescence in response to Fe
deficiency in the presence or absence of ferrichrome.
Found at: doi:10.1371/journal.ppat.1001322.s001 (2.67 MB TIF)
Figure S2 C. glabrata survival kinetics and characterization of
activated mouse macrophages. A. Kinetics of C. glabrata survival
within activated macrophages in the presence or absence of
ferrichrome. Infection of macrophages with C. glabrata wild type,
sit1 D and SIT1-reconstituted strains was performed as described in
Materials and Methods. C. glabrata cells were recovered at the
indicated time-points and CFU determined. B. Culturing macro-
phages in high exogenous Fe conditions leads to an increase in
intracellular Fe stores. Macrophages were cultured for 2 days in the
presence or absence of Fe supplementation in the culture medium.
Cells were harvested and processed for the isolation of total protein.
C. Macrophage Fe-loading does not lead to an overt defect in
activation as evaluated by TNF-a secretion. J774A.1 macrophages
were grown in the presence or absence of 10 mM ferric ammonium
citrate for 2 days and activated with 5 ng/ml IFN-c and 1 mg/ml
LPS for 3 hours. The supernatant was collected and processed for
ELISA. D. The generation of reactive oxidative species was
quantified by monitoring the conversion of DCFH-DA into the
highly fluorescent DCF. Macrophages were either untreated
(control) or exposed to LPS/IFN-c or menadione (250 mM) for 3
hours and DCFH-DA (20 mM) added to the samples during the last
30 minutes. Absorbance was read at 520 nm. The results shown are
mean fluorescence (AU) of 8 replicates per sample and the bars
show the standard error of the mean.
Found at: doi:10.1371/journal.ppat.1001322.s002 (0.47 MB TIF)
Figure S3 Characterization of the Fpn cell lines. A. Fpn
localization in macrophage stable cell lines expressing wild type
and mutant forms of Fpn. Indirect immunofluoresence was used to
evaluate the localization of Fpn in the presence or absence of
hepcidin. White arrows indicate the cell surface localization of Fpn
most evident on psudopod formations. B. Macrophage stable cell
lines expressing wild type and mutant forms of Fpn are capable of
mounting an inflammatory response. Supernatants from stable cell
lines expressing wild type or ferroportin mutation alleles were
treated as described above and the supernatants collected for
ELISA. Control - non-transfected J774A.1 cells.
Found at: doi:10.1371/journal.ppat.1001322.s003 (1.34 MB TIF)
Figure S4 Identification of the Sit1 SITD. Representative
BLAST results retrieved using a 51-residue sequence comprising
the predicted carboxyl-terminal loop. Representative set of the 91
Siderophores Promote C. glabrata Survival
PLoS Pathogens | www.plospathogens.org 13 March 2011 | Volume 7 | Issue 3 | e1001322hits obtained is shown. Mutation of Sit1
Y575A was performed using
site-directed mutagenesis.
Found at: doi:10.1371/journal.ppat.1001322.s004 (2.14 MB TIF)
Figure S5 The integrity of the Sit1 carboxyl-terminal loop is
critical for siderophore utilization. A. Schematic illustration of the
localization of the Flag epitope introduced within the carboxyl-
terminal loop. B. Sit1-SITDFlag localizes to the plasma mem-
brane in non-permeabilized cells. Cells carrying the Sit1-SITD-
Flag construct of vector alone were grown under Fe deficiency and
subjected to indirect immunofluorescence using anti-Flag anti-
body. C. Schematic illustration of the Sit1
Y575A substitution
introduced into the SIT1MCHERRY construct and integrated at
the SIT1 endogenous locus. D. Sit1 protein levels of the wild type
and Sit1
Y575A strains under Fe deficiency or Fe sufficiency. Cells
were grown either under Fe deficiency by supplementation of BPS
to the growth medium or Fe sufficiency by the further
supplementation of ferrichrome for 3 hours. Cells were harvested
and processed for protein analysis. E Subcellular localization of the
Sit1
Y575AFlag mutant protein. The mutant transporter was
expressed episomally and its subcellular localization evaluated by
indirect immunoflourescence of the Flag epitope.
Found at: doi:10.1371/journal.ppat.1001322.s005 (1.30 MB TIF)
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